戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ectious cDNA clone of a genotype 3 strain of hepatitis E virus adapted to growth in HepG2/C3A human h
2 elm mottle virus, in animal viruses like the hepatitis E virus and the caprine encephalitis virus, an
3 ted in 75 of 108 (69%) patients, antibody to hepatitis E virus (anti-HEV) in three patients (3%), and
4                      To evaluate antibody to hepatitis E virus (anti-HEV) seroreactivity, 5000 US blo
5           Baseline prevalence of antibody to hepatitis E virus (anti-HEV) was 22.5%.
6 mance of existing assays for antibody to the hepatitis E virus (anti-HEV).
7                         If the occurrence of hepatitis E virus antibody (anti-HEV) in regions where t
8 haracterized a novel virus, designated avian hepatitis E virus (avian HEV), from chickens with hepati
9 ulation: human T-cell leukemia virus type 1; hepatitis E virus; bocavirus; KI and WU polyomaviruses;
10                                   Based on a hepatitis E virus capsid model, we performed homology mo
11 a-barrel structure that is also found in the hepatitis E virus capsid protrusions, suggesting a close
12 owever, recent work on hepatitis A virus and hepatitis E virus challenges this long-held tenet.
13 , the ICTV approved a proposal to remove the hepatitis E virus from the Caliciviridae into an "unassi
14                                              Hepatitis E virus genotype 1 strain Sar55 replicated in
15  that sofosbuvir inhibits the replication of hepatitis E virus genotype 3 both in subgenomic replicon
16                               Infection with hepatitis E virus genotype 3 may result in chronic hepat
17                                              Hepatitis E virus has been reported to result in chronic
18 odies against the emerging zoonotic pathogen hepatitis E virus (HEV) and enteropathogenic Yersinia sp
19            The thermal stability of virulent hepatitis E virus (HEV) and hepatitis A virus (HAV) was
20 he host responses to two dissimilar viruses, hepatitis E virus (HEV) and hepatitis C virus (HCV), wer
21 s have shown a relatively high prevalence of hepatitis E virus (HEV) antibody.
22                                              Hepatitis E virus (HEV) can chronically infect immunocom
23 -strands similar to what was observed in the hepatitis E virus (HEV) capsid structure.
24                                              Hepatitis E virus (HEV) causes both endemic and epidemic
25                                              Hepatitis E virus (HEV) causes outbreaks of jaundice ass
26                        The RNA genome of the hepatitis E virus (HEV) contains a hypervariable region
27 ntigen derived from the Meng strain of swine hepatitis E virus (HEV) differs from that of the Sar-55
28                     All patients cleared the hepatitis E virus (HEV) except for 2 (nonresponders); 1
29 L) structure in the intergenic region of the hepatitis E virus (HEV) genome in virus replication were
30                                              Hepatitis E virus (HEV) genotype 3 infections are freque
31                            The prevalence of hepatitis E virus (HEV) genotype 3 infections in the Eng
32 ports of food-borne zoonotic transmission of hepatitis E virus (HEV) genotype 3, which causes chronic
33            We estimated the global burden of hepatitis E virus (HEV) genotypes 1 and 2 in 2005.
34                                              Hepatitis E virus (HEV) has been recognized as a threat
35                                              Hepatitis E virus (HEV) has emerged as a cause of chroni
36                                              Hepatitis E virus (HEV) has recently been cloned and seq
37         Moreover, a high prevalence (17%) of hepatitis E virus (HEV) immunoglobulin G antibodies (ant
38 sceptible humans may serve as a reservoir of hepatitis E virus (HEV) in areas in which HEV is endemic
39 ce and molecular characterisation studies of hepatitis E virus (HEV) in England and Wales have been u
40     The recent identification of antibody to hepatitis E virus (HEV) in pigs, sheep, and cattle and c
41 amination and evaluate the dispersion of the hepatitis E virus (HEV) in the environment.
42                                              Hepatitis E virus (HEV) induces acute hepatitis in human
43         Transplant recipients are at risk of hepatitis E virus (HEV) infection and could be vulnerabl
44                                     However, hepatitis E virus (HEV) infection can also be acquired i
45                                              Hepatitis E virus (HEV) infection causes major epidemics
46 ntiviral immunity and immunopathology during hepatitis E virus (HEV) infection determines important c
47                                              Hepatitis E virus (HEV) infection has been proposed as a
48 ical and laboratory features, and outcome of hepatitis E virus (HEV) infection in children.
49 nd a relatively high seroprevalence (21%) of hepatitis E virus (HEV) infection in the U.S. general po
50                                        Acute hepatitis E virus (HEV) infection is a leading cause of
51                           BACKGROUND & AIMS: Hepatitis E virus (HEV) infection is a major cause of ac
52                                      Chronic hepatitis E virus (HEV) infection is a significant clini
53                                              Hepatitis E virus (HEV) infection is an emerging disease
54                                              Hepatitis E virus (HEV) infection is increasingly being
55                                              Hepatitis E virus (HEV) infection is usually self-limite
56 nsitivity to exogenous type I IFN.IMPORTANCE Hepatitis E virus (HEV) infection typically causes self-
57 protective efficacy of a DNA vaccine against hepatitis E virus (HEV) infection was tested in cynomolg
58   Prevalence of antibody and risk factors to hepatitis E virus (HEV) infection were determined in a c
59          There is no established therapy for hepatitis E virus (HEV) infection.
60                                              Hepatitis E virus (HEV) infections are a major cause of
61      Antiviral treatment options for chronic Hepatitis E Virus (HEV) infections are limited and immun
62                                        Among hepatitis E virus (HEV) infections diagnosed in 2011 by
63 lid-organ-transplant recipients with chronic hepatitis E virus (HEV) infections were given ribavirin
64          There is little knowledge about how hepatitis E virus (HEV) inhibits induction of host IFNs,
65                                              Hepatitis E virus (HEV) is a causative agent of acute he
66                                              Hepatitis E virus (HEV) is a human pathogen that causes
67                                              Hepatitis E virus (HEV) is a major cause of acute viral
68                          The ORF3 protein of hepatitis E virus (HEV) is a multifunctional protein imp
69                                              Hepatitis E virus (HEV) is a new causative agent of chro
70                                              Hepatitis E virus (HEV) is a single-strand positive-sens
71                                              Hepatitis E virus (HEV) is an emerging virus causing epi
72                                              Hepatitis E virus (HEV) is an important but extremely un
73                                              Hepatitis E virus (HEV) is an important but extremely un
74                                              Hepatitis E virus (HEV) is an important cause of enteric
75                                              Hepatitis E virus (HEV) is an important human pathogen,
76                                              Hepatitis E virus (HEV) is an important human pathogen.
77                                              Hepatitis E virus (HEV) is an important public health co
78                                              Hepatitis E virus (HEV) is an unclassified virus with a
79                                              Hepatitis E virus (HEV) is believed to be transmitted by
80                                  Exposure to hepatitis E virus (HEV) is common in the United States,
81                                              Hepatitis E virus (HEV) is considered a zoonotic infecti
82                                              Hepatitis E virus (HEV) is endemic in many developing an
83                                              Hepatitis E virus (HEV) is increasingly acknowledged as
84 ferent hosts in genotypes 3 and 4.IMPORTANCE Hepatitis E virus (HEV) is increasingly recognized as a
85                                              Hepatitis E virus (HEV) is prevalent and causes disease
86                                     Although hepatitis E virus (HEV) is regarded as a self-limiting i
87                                              Hepatitis E virus (HEV) is the causative agent of hepati
88                                              Hepatitis E virus (HEV) is the leading cause of enterica
89                                              Hepatitis E virus (HEV) is the major cause of entericall
90                                              Hepatitis E virus (HEV) is the most common cause of acut
91                                              Hepatitis E virus (HEV) is the most common cause of acut
92                               The RNA virus, hepatitis E virus (HEV) is the most or second-most impor
93                                              Hepatitis E virus (HEV) is yearly responsible for approx
94  To determine the initiation strategy of the hepatitis E virus (HEV) open reading frame 3 (ORF3), we
95                                          The hepatitis E virus (HEV) polyproline region (PPR) is an i
96              As a positive-strand RNA virus, hepatitis E virus (HEV) produces an intermediate negativ
97             The antigenic composition of the hepatitis E virus (HEV) protein encoded by open reading
98                                              Hepatitis E virus (HEV) recently has been shown to be an
99                                              Hepatitis E virus (HEV) replication is not well understo
100                             The mechanism of hepatitis E virus (HEV) replication remains largely unkn
101                                          The hepatitis E virus (HEV) RNA concentrations were determin
102                                              Hepatitis E virus (HEV) RNA replication occurred in seve
103                                              Hepatitis E virus (HEV) seroprevalences of 0.3%-53% were
104   Here, we report that the macro domain from hepatitis E virus (HEV) serves as an ADP-ribose-protein
105                                          The hepatitis E virus (HEV) sheds into feces as nonenveloped
106                        The classification of hepatitis E virus (HEV) variants is currently in transit
107 with HUE (58.3%) and the pooled library, and hepatitis E virus (HEV) was detected in 2 individuals wi
108 nst the ORF2 protein of the SAR-55 strain of hepatitis E virus (HEV) were isolated by phage display f
109                                        Avian hepatitis E virus (HEV), a novel virus identified from c
110                                              Hepatitis E virus (HEV), a single-stranded positive-sens
111                                              Hepatitis E virus (HEV), a small, non-enveloped RNA viru
112 ut how broadly enzootic its causative agent, hepatitis E virus (HEV), is remains controversial.
113                                              Hepatitis E virus (HEV), rotavirus (RV), and astrovirus
114                                              Hepatitis E virus (HEV), the causative agent of hepatiti
115                               The effects of hepatitis E virus (HEV), the causative agent of hepatiti
116 s a striking resemblance to the structure of hepatitis E virus (HEV)-like particles, as previously pr
117 en-free pigs were inoculated with one of two hepatitis E viruses (HEV) (one recovered from a pig and
118 itis-B virus (HBV), hepatitis-C virus (HCV), hepatitis-E virus (HEV), dengue virus (DENV), and West N
119 gical and molecular techniques (detection of hepatitis E virus [HEV] RNA from stool and serum samples
120                                   Genotype 1 hepatitis E viruses (HEVs) are restricted to primate hos
121                                              Hepatitis E virus IgM and IgG reactivity was determined.
122                                              Hepatitis E virus IgM and IgG reactivity.
123            The seroprevalence of antibody to hepatitis E virus in this population was 13.6%; to Barto
124 ral blood and liver tissue revealed an acute hepatitis E virus infection (genotype 3).
125                                              Hepatitis E virus infection causes an acute hepatitis wi
126   Ribavirin is efficient at treating chronic hepatitis E virus infection in solid-organ transplant pa
127 ts with a solid-organ transplant and chronic hepatitis E virus infection were given ribavirin for 3 m
128                                      Chronic hepatitis E virus infection with rapid progression to ci
129                                              Hepatitis E virus is a nonenveloped RNA virus.
130                                              Hepatitis E Virus-like particles self-assemble in to non
131                                              Hepatitis E virus recombinant genomes transcribed in vit
132                        We also recruited non-hepatitis E virus-related pregnant (P), ALF-NE (n = 5) a
133                                              Hepatitis E virus replicons containing the neomycin resi
134                                              Hepatitis E virus RNA levels also remained detectable in
135  related to the P1 domain in calicivirus and hepatitis E virus, suggesting a possible evolutionary re
136   Prior to the recent discovery of the swine hepatitis E virus (swine HEV) in pigs from the midwester
137                                        Swine hepatitis E virus (swine HEV), the first animal strain o
138              A novel virus, designated swine hepatitis E virus (swine HEV), was identified in pigs.
139                               In the case of hepatitis E virus, the adjacent viral helicase domain dr
140 ul new tool in the prevention and control of hepatitis E virus transmission and disease.
141 ly efficiently transfected and infected with hepatitis E virus was identified.
142                  An infectious cDNA clone of hepatitis E virus was mutated in order to prevent synthe

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top